Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Frontiers in Bioengineering and Biotechnology|April 24, 2023
Key aspects for conception and construction of co-culture models of tumor-stroma interactionsJames Mason, Daniel Öhlund
The Journal of Experimental Medicine|July 30, 2014
Fibroblast heterogeneity in the cancer woundDaniel Öhlund, Ela Elyada, David Tuveson
Frontiers in Cell and Developmental Biology|December 13, 2021
Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical TraitsParniyan Maneshi, James Mason, Mitesh Dongre, et al.
BMC Cancer|March 28, 2013
Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loopDaniel Öhlund, Oskar Franklin, Erik Lundberg, et al.
Frontiers in Genetics|September 18, 2023
Dysregulation of core neurodevelopmental pathways-a common feature of cancers with perineural invasionLuz María González-Castrillón, Maud Wurmser, Daniel Öhlund, et al.
Biochemical Pharmacology|August 17, 2024
Overcoming therapy resistance in pancreatic cancer: New insights and future directionsMargarita Espona-Fiedler, Cedric Patthey, Stina Lindblad, et al.
Cancer Biomarkers : Section a of Disease Markers|December 20, 2014
Combining conventional and stroma-derived tumour markers in pancreatic ductal adenocarcinomaOskar Franklin, Daniel Öhlund, Christina Lundin, et al.
Cancers|November 5, 2020
Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic CancerAndrii Khomiak, Marius Brunner, Maximilian Kordes, et al.
Familial Cancer|March 5, 2024
Can our experience with surveillance for inherited pancreatic cancer help to identify early pancreatic cancer in the general population?J-Matthias Löhr, Daniel Öhlund, Emma Söreskog, et al.
The Journal of Pathology. Clinical Research|November 21, 2018
Novel prognostic markers within the CD44-stromal ligand network in pancreatic cancerOskar Franklin, Ola Billing, Daniel Öhlund, et al.
Pageof 5